نتایج جستجو برای: acute lymphocytic leukemia

تعداد نتایج: 694854  

MicroRNAs are small, non-coding sequences that regulate gene expression by inducing degradation or translational inhibition of target mRNAs. These molecules control many intracellular physiological and pathological processes.Abnormal expression of these moleculs has been described in different cancers including hematopoietic cancers. According to the type of cancer and the stage, miRNA’s expres...

Journal: :European review for medical and pharmacological sciences 2014
L-R Qian W Fu J-L Shen

Although treatment results for adult acute lymphoblastic leukemia (ALL) have improved considerably in the past decades, treating adult patients with relapsed/refractory acute lymphocytic leukemia (ALL) is still difficult. Adults with refractory/relapsed acute lymphocytic leukemia (ALL) processed to death rapidly associated with chemotherapy resistance, high mortality by reinduction, etc. Only 2...

Journal: :iranian journal of pharmaceutical research 0
ma ghaffari m kadkhodaei-elyaderani mr saffari m pedram

nitric oxide (no) is a molecule required for many physiological functions, produced from l-arginine by no synthases (nos). it is a free radical, producing many reactive intermediates that account for its bioactivity. sustained induction of the inducible form of nos (inos) in chronic inflammation may be mutagenic, through no-mediated dna damage or hindrance to dna repair, and thus potentially ca...

Journal: :Electronics 2023

A cancer diagnosis is one of the most difficult medical challenges. Leukemia a type that affects bone marrow and/or blood and accounts for approximately 8% all cancers. Understanding epidemiology trends leukemia critical planning. Specialists diagnose using morphological analysis, but there possibility error in diagnosis. Since so to diagnose, intelligent methods are required. The primary goal ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 1988
A Neri D M Knowles A Greco F McCormick R Dalla-Favera

We investigated the frequency of mutations activating RAS oncogenes in human lymphoid malignancies, including B- and T-cell-derived acute lymphoblastic leukemia, chronic lymphocytic leukemia, and non-Hodgkin lymphoma. By the polymerase chain reaction/oligonucleotide hybridization method, DNA from 178 cases was analyzed for activating mutations involving codons 12 and 61 of the HRAS, KRAS and NR...

2013
Juliana Godoy Assumpção Francisco Danilo Ferreira Paula Sandra Guerra Xavier Mitiko Murao Joaquim Caetano de Aguirre Álvaro Pimenta Dutra Eduardo Ribeiro Lima Benigna Maria de Oliveira Marcos Borato Viana

OBJECTIVE To detect markers for minimal residual disease monitoring based on conventional polymerase chain reaction for immunoglobulin, T-cell receptor rearrangements and the Sil-Tal1 deletion in patients with acute lymphocytic leukemia. METHODS Fifty-nine children with acute lymphocytic leukemia from three institutions in Minas Gerais, Brazil, were prospectively studied. Clonal rearrangement...

Journal: :Journal of Rawalpindi Medical College (Print) 2022


 Acute Lymphocytic leukemia (ALL) is the most common childhood malignancy, CNS involvement occurs in 3-5% of patients. We present a case 14-year-old boy who presented to us with nighttime fever, headache, and right-sided focal fits. Reports showed decreased platelets, increased WBC predominant eosinophils imaging subgaleal, epidural subdural collection. Bone marrow biopsy CSF analysis wer...

Journal: :iranian journal of cancer prevention 0
mehrdad payandeh 1. pennathur a, gibson mk, jobe ba, luketich jd. oesophageal carcinoma.lancet. 2013;381(9864):400-12. 2. ferlay j, shin hr, bray f, forman d, mathers c, parkin dm.estimates of worldwide burden of cancer in 2008: globocan 2008. int j cancer. 2010;127:2893–917. 3. lepage c, rachet b, jooste v, faivre j, coleman mp. continuing rapid increase in sophageal adenocarcinoma in england and wales. am j gastroentero.l 2008;103 2694–99. 4. pennathur a, farkas a, krasinskas am. esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. ann thorac surg. 2009;87:1048–55. 5. mir mr, rajabpour mv, delarestaghi mm, hadji m, harirchi i, mir p, mir a, lashkari m, zendehdel k. short- and long-term survival of esophageal cancer patients treated at the cancer institute of iran. dig surg. 2013;30(4-6):331-6. 6. harirchi i, kolahdoozan s, hajizadeh s, safari f, sedighi z, nahvijou a, mir mr, mousavi sm, zendehdel k. esophageal cancer in iran; a population-based study regarding adequacy of cancer surgery and overall survival. eur j surg oncol. 2014;40(3):352-7. 7. pennathur a, luketich jd. resection for esophageal cancer:strategies for optimal management. ann thorac surg. 2008;85:751–56. 8. pennathur a, zhang j, chen h, luketich jd. the “best operation”for esophageal cancer? ann thorac surg. 2010;89:2163–67. 9. davies ar, forshaw mj, khan aa, noorani as, patel vm, strauss dc, mason rc. transhiatal esophagectomy in a high volume institution. world j surg oncol. 2008 ;6:88. 10. chang ac, ji h, birkmeyer nj, orringer mb, birkmeyer jd. outcomes after transhiatal and transthoracic esophagectomy for cancer. ann thorac surg. 2008;85(2):424-9. 11. nikbakhsh n, amri p, shakeri a, shakeri a. changes in blood pressure and heart rhythm during transhiatal esophagectomy.caspian j intern med. 2012;3(4):541-5. 12. mallipeddi mk, onaitis mw. the contemporary role of minimally invasive esophagectomy in esophageal cancer. curr oncol rep. 2014;16(3):374. 13. sundaram a, geronimo jc, willer bl, hoshino m, torgersen z, juhasz a, lee th, mittal sk. survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience. surg endosc. 2012;26(1):168-76. 14. herbella fa, patti mg. minimally invasive esophagectomy. world j gastroenterol. 2010;16(30):3811-5. 15. rice tw, blackstone eh, rusch vw. 7th edition of the ajcc cancer staging manual: esophagus and esophagogastric junction.ann surg oncol. 2010;17(7):1721-4 16. d'journo xb, thomas pa. current management of esophageal cancer. j thorac dis. 2014;6 suppl 2:s253-64. 17.hoppo t, jobe ba, hunter jg. minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. world j surg. 2011;35(7):1454-63. 18. dhamija a, dhamija a, hancock j, mccloskey b, kim aw, detterbeck fc, boffa dj. minimally invasive oesophagectomy more expensive than open despite shorter length of stay. eur j cardiothorac surg. 2014;45(5):904-9. 19. galvani ca, gorodner mv, moser f, jacobsen g, chretien c, espat nj, donahue p, horgan s. robotically assisted laparoscopic transhiatal esophagectomy. surg endosc. 2008;22(1):188-95. 20. nguyen nt, hinojosa mw, smith br, chang kj, gray j, hoyt d. minimally invasive esophagectomy: lessons learned from 104 operations. ann surg. 2008;248(6):1081-91. 21. dunn dh, johnson em, morphew ja, dilworth hp, krueger jl, banerji n. robot-assisted transhiatal esophagectomy: a 3-year single-center experience. dis esophagus. 2013;26(2):159-66. 22. maas kw, biere ss, scheepers jj, gisbertz ss, van-der-peet dl, cuesta ma. laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. rev esp enferm dig. 2012;104(4):197-202. 23. rizvi fh, rizvi ss, syed aa, khattak s, khan ar. minimally invasive esophagectomy for esophageal cancer: the first experience from pakistan. int j surg oncol. 2014;2014:864705. 24. tabatabaie sa., hashemi sm,, mohajeri gh,ahmadinejad m, goharian v, kolahdoozan m.,sehhat s, davarpanah ah. incidence of hypotension and type of arrhythmia in transhiatal esophagectomy and evaluation of related factors.iranian journal of surgery. 2009;16(4):59-68. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran masoud sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran edris sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran

1. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran 2. students research committee, kermanshah university of medical sciences, kermanshah, iran 3. medical biology research center, kermanshah university of medical sciences, kermanshah, iran                                     corresponding author: masoud sadeghi, msc. tel: (+98) 9185960644 ema...

ژورنال: :iranian red crescent medical journal 0
hamideh jafari ghahfarokhi cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran saeede ashoori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran mohamad taghi akbari department of medical genetics, faculty of medical sciences, tarbiat modares university, tehran, ir iran masoud lotfizadeh department of public health, social health determinants research center, school of health, shahrekord university of medical sciences, shahrekord, ir iran ali karimi medical plant research center, shahrekord university of medical sciences, shahrekord, ir iran hossein teimori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran; cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran. tel: +98-3813346692, fax: +98-3813330709

background b-cell chronic lymphocytic leukemia (b-cll) is the most common form of leukemia in adults. some reports showed that expression of zap70 gene and chromosomal abnormality are two prognostic factors in management of b-cll objectives in this study, we determined zap70 mrna expression level in the del17p13, del6q21 and del11q13 subgroups of iranian b-cll patients to investigate prognostic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید